Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study

Por Ng, Kok Pin, Ng, Aloysius, Assam, Pryseley, Heng, Esther, Kandiah, Nagaendran
Publicado em 2014

Voluntary cognitive screening: characteristics of participants in an Asian setting

Por Ho, Vanda, Zainal, Nur Hani, Lim, Linda, Ng, Aloysius, Silva, Eveline, Kandiah, Nagaendran
Publicado no Clin Interv Aging (2015)

Opt-out of Voluntary HIV Testing: A Singapore Hospital's Experience

Por Chua, Arlene C., Leo, Yee Sin, Cavailler, Philippe, Chu, Christine, Ng, Aloysius, Ng, Oon Tek, Krishnan, Prabha
Publicado em 2012

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease

Por Foo, Heidi, Mak, Elijah, Chander, Russell Jude, Ng, Aloysius, Au, Wing Lok, Sitoh, Yih Yian, Tan, Louis C.S., Kandiah, Nagaendran
Publicado no Neuroimage Clin (2016)

Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke

Por Chander, Russell J., Lam, Bonnie Y. K., Lin, Xuling, Ng, Aloysius Y. T., Wong, Adrian P. L., Mok, Vincent C. T., Kandiah, Nagaendran
Publicado no Sci Rep (2017)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)

Por Huang, Ruby Yun-Ju, Kuay, Kuee Theng, Tan, Tuan Zea, Asad, Mohammad, Tang, Hei Mui, Ng, Aloysius Hsien Chun, Ye, Jieru, Chung, Vin Yee, Thiery, Jean Paul
Publicado no Oncotarget (2015)